Phase I Trial to Determine Safety/Tolerability of Ex Viv

Project: Research project

Project Details

Description

A Phase I Trial to Determine Safety and Tolerability of Ex Vivo Expanded Human Myeloid Progenitor Cells (CLT-008) Infused 24 Hours Post-Transplant to Support Allogeneic Umbilical Cord Blood Transplantation for Hematologic Malignancies
StatusFinished
Effective start/end date12/1/0812/31/14

Funding

  • CELLERANT THERAPEUTICS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.